Effectiveness, Safety and Utilization of Vismodegib for Locally Advanced Basal Cell Carcinoma Under Real-world Conditions: Non-interventional Cohort Study JONAS

Effectiveness, Safety and Utilization of Vismodegib for Locally Advanced Basal Cell Carcinoma Under Real-world Conditions: Non-interventional Cohort Study JONAS

Most patients with advanced basal cell carcinomas (BCCs) may not benefit sufficiently from standard treatment comprising surgery and radiation. Vismodegib, an oral selective hedgehog pathway inhibitor, is approved for treatment of patients with locally advanced BCC inappropriate for surgery or radio...

Full description

Bibliographic Details
Main Authors: Martin Kaatz, Peter Mohr, Elisabeth Livingstone, Michael Weichenthal, Alexander Kreuter, Claudia Pföhler, Ulrike Leiter, Jens Ulrich, Jochen Sven Utikal, Ralf Gutzmer, Rudolf Herbst, Dirk Schadendorf
Format: Article
Language:English
Published: Medical Journals Sweden 2022-04-01
Series:Acta Dermato-Venereologica
Subjects:
Locally advanced basal cell carcinoma
Vismodegib
Effectiveness
Safety
Non-interventional study
German ADOReg skin cancer registry
Online Access:https://medicaljournalssweden.se/actadv/article/view/293

Internet

https://medicaljournalssweden.se/actadv/article/view/293

Similar Items